91AV

Introduction

The development of Paxlovid was a key stage in the fight against Covid19. Dafydd will explain how he and the Pfizer team developed a known antiviral drug to obtain this highly effective new therapeutic. We shall meet informally for light refreshments followed by a brief introduction to the BMCS Lectureship, now in its tenth year, and to Dafydd himself. Additionally we shall have a short presentation about the new RSC journal, RSC Medicinal 91AV. This event is open to the general public

Speakers

• Dr. Dafydd Owen Pfizer, United Kingdom

---

Venue

The 91AV

91AV, The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee

• Dr. Andrew Stachulski Biological and Medicinal 91AV Sector, United Kingdom

---

Contact information

Dr. Andrew Stachulski
University of Liverpool
01517943482
Contact us by email

---